 Home > Biochemistry News > Biotechnology News > Phase 1 clinical trial of mRNA vaccine to prevent seasonal influenza has started

Phase 1 clinical trial of mRNA vaccine to prevent seasonal influenza has started

 Last Update: 2021-08-08
 Source: Internet
 Author: User

Tags

black 2.0 vantablack

mrna manufacturing

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On June 22, 2021, Sanofi's global vaccine development division, Sanofi Pasteur and Translate Bio announced that the next-generation mRNA seasonal influenza vaccine jointly developed by the two parties has started phase 1.

The global number of deaths related to influenza is between 290,000 and 650,000 each year, and there are approximately 10 million influenza-related hospitalized cases

As early as June 2018, the two companies signed a cooperation and exclusive license agreement to combine Sanofi Pasteur’s expertise in vaccines with Translate Bio’s mRNA R&D expertise to develop targets for five infectious disease pathogens MRNA vaccine

Note: The original text has been deleted

Reference materials:

[1] Sanofi and Translate Bio Initiate Phase 1 Clinical Trial of mRNA Influenza Vaccine.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.